Sign In / Sign Out
- ASU Home
- My ASU
- Colleges and Schools
- Map and Locations
Corey Dubin is the president of the Committee of Ten Thousand (COTT), founded in 1989 for persons with hemophilia who contracted HIV/AIDS and Hepatitis C from tainted blood products in the late 1970s and 1980s. After joining with COTT in 1992 Mr. Dubin was the first grass roots end user of our nation's blood supply to be appointed to the Food and Drug Administration (FDA) Blood Products Advisory Committee. He, with others from the HIV/AIDS infected Hemophilia community, was instrumental in the passage of the Ricky Ray Hemophilia Relief Fund Act of 1999. Mr. Dubin also worked closely with the Institute of Medicine, National Academy of Sciences Committee to Study HIV Transmission Through Blood and Blood Products to produce "HIV and the Blood Supply, An Analysis of Crisis Decision-making" in 1995. COTT and Mr. Dubin continue to be active and insightful advocates for a safe and available national blood supply for all Americans. In March of 2012 he was again appointed to the FDA Blood Products Advisory Committee to advocate for end user communities as a full stakeholder. Mr. Dubin is a member of "The Triple-H Club", a termed used by the hemophilia community, meaning a person with hemophilia who also has been infected with HIV/AIDS and Hepatitis C.
Prior to joining COTT, he was chair of the Santa Barbara County HIV/AIDS Ryan White Title II Consortia. He served in that role for 5 years and was also appointed to the State of California State-wide Title II Working group. In 1993 he was also appointed to the California Community Planning Working Group. The CPWG was tasked to draft California’s HIV/AIDS Prevention Plan for the 1990′s. He served on that Group until 1999 and served as one of the Co-Chairs of the Working Group for one year. Previous to the HIV/AIDS Hemophilia epidemic he was a sucessful radio and print journalist covering Latin America and US foreign Policy.
Thomas Higgins is a co-founder and CEO of Berkeley Energy Sciences Corp, an early stage, grid scale energy storage company. BESC utilizes a highly innovative flywheel technology to solve critical problems around the sustainable generation of electricity from renewable resources and the efficient distribution of electricity.
He was previously the founding chief executive of Prosetta Corporation, a breakthrough biotechnology company focused on anti-viral drug discovery and development in San Francisco, Ca. He served as the president and CEO from 2003-2008. Prior to that, he was president and chief operating officer of Business for Social Responsibility. BSR is the leading global resource for businesses seeking to improve their performance in areas of corporate social responsibility.
Higgins served in the administration of President Carter, beginning as a senior executive at HEW, where he was Director of Region VII, and at HHS, as Associate Commissioner of the Social Security Administration. His service culminated as a presidential appointee on the White House Senior Staff, where he served as Deputy Secretary to the Cabinet.
After earlier career experience as a newspaper reporter and gubernatorial campaign manager, Higgins became the founder and executive director of a multi-service drug abuse treatment program in the Illinois-Iowa Quad Cities in the early 1970s. Subsequently, he was elected to the Iowa General Assembly at the age of 27, where he served three terms and was chairman of the Human Resources Committee, before resigning to serve in the Carter administration. In the early 1980s he was the head of the Health and Social Services Department in Portland, Oregon, which established several new models of local health care finance and delivery.
In 1983, he began his private sector career as founding Publisher and President of The Business Journal in Portland, published by American Cities Business Journals. Subsequently, Higgins became the co-founder and editor-in-chief of HealthWeek, a national newspaper covering health business news in the United States, published by CMP Publications.
In 1990, Higgins was recruited as a vice president of Blue Cross/Blue Shield of Maryland. He was subsequently elected a Senior Vice President of the company, with broad responsibilities for operations and staff organizations at BC/BS, as well as its subsidiary holdings.
Higgins began his career at Southern California Edison and Edison International in 1995, serving as a Senior Vice President. Edison is a $15 billion power generation and electric distribution company. During his career with the company, Higgins served on the management committee and helped to set overall strategy for the company. He had responsibility for several staff functions and was president of Edison Enterprises, an unregulated subsidiary.
Higgins has a distinguished record of business and community service. He currently serves on the boards of directors of SCAN Health Plan, Akonni Biosystems and Prosetta. He is a member of the Board of Trustees of St. Ambrose University, where he graduated cum laude in 1967. He also serves as chairman of the board of The SCAN Foundation, an independent philanthropy focused on reform of long term care in America.
Dr. Kristen M. Kulinowski is an expert in the environmental, health, and safety implications of nanomaterials (nano-EHS). She currently serves as a Research Staff Member at the Science and Technology Policy Institute (STPI), a federally funded research and development center in Washington DC that provides analytical support to the White House Office of Science and Technology Policy and other Federal agencies. Prior to joining STPI in 2011, she was at Rice University as Senior Faculty Fellow in Chemistry, Executive Director for the Center for Biological and Environmental Nanotechnology (CBEN) and the Director of the International Council on Nanotechnology (ICON).
Dr. Kulinowski published the first database of citations to peer-reviewed nano-EHS papers, a survey of best practices for nanomaterial workplaces, and the GoodNanoGuide, an interactive forum for sharing information about nanomaterial handling practices. Dr. Kulinowski has advised governments in North America, Europe, Africa, and Asia on nanotechnology policy issues. She is co-author of a National Institute for Environmental Health Sciences white paper on training hazardous waste workers to handle nanomaterials and was principal investigator on an Occupational Safety and Health Administration grant to develop instructional materials to assist companies in creating and sustaining safer nanomaterial workplaces.
She was selected in 2001 as the Congressional Science Policy Fellow of the Optical Society of America and SPIE-The International Society of Optical Engineers and served her term in the office of Rep. Edward J. Markey (MA-07) working on a broad set of issues including chemical, biological and nuclear nonproliferation, domestic nuclear security, and public health. Dr. Kulinowski received a B.S. degree in chemistry with honors from Canisius College and M.S. and Ph.D. degrees in chemistry from the University of Rochester.
Celia Merzbacher is Vice President for Innovative Partnerships at the Semiconductor Research Corporation (SRC), a nonprofit industry consortium that invests in basic research at universities to address industry needs. She is responsible for developing new initiatives and partnerships with stakeholders in government and the private sector in support of SRC’s research and education goals.
Prior to joining SRC, Dr. Merzbacher was Assistant Director for Technology R&D in the White House Office of Science and Technology Policy (OSTP), where she oversaw the National Nanotechnology Initiative and advised on a range of issues, including technology transfer, technical standards, and intellectual property. She also served as Executive Director of the President’s Council of Advisors on Science and Technology.
Previously, Dr. Merzbacher was on the staff of the Naval Research Laboratory in Washington D.C., where as a research scientist, she developed advanced materials, which led to numerous publications and five patents. As a researcher, she managed a mentoring program for young NRL scientists. She also held an executive position in the NRL Technology Transfer Office.
Dr. Merzbacher served on the Board of Directors of the American National Standards Institute and led the U.S. delegation to the Organization for Economic Cooperation and Development Working Party on Nanotechnology. She currently is on the National Research Council committee to review the National Nanotechnology Initiative and is on a number of industry and academic advisory boards.
Lee Seabrooke is a seasoned professional and leader in the clinical and translational research arena, which includes a background in research regulatory affairs and ethics. Currently, he serves as the Director of Research for the Banner MD Anderson Cancer Center in the Phoenix metropolitan area.
He has worked as the primarily regulatory and research ethics officer for research activities at The Methodist Hospital Research Institute in Houston, Texas and provided regulatory oversight of pre-clinical research activities and conflicts of interest in research for The University of Texas MD Anderson Cancer Center in Houston, Texas. He has served as faculty for numerous domestic and international research conferences and symposia and has a background in domestic and international consulting in the areas of clinical and translational research policy and ethics. His interests include regulatory science, capital mechanisms, and research policy in the areas of personalized medicine and oncology.
Cyndy Schwartz is Environmental Health and Safety Manager for US Operations for M+W US Inc., a global semiconductor construction firm. She has directed operations, quality control, and health and safety activities for numerous companies in the semiconductor industry, including Tokyo Electron, Albany Nanotech / Nanoengineering, Materials Research Corporation, Electronic Data Solutions, Fairchild Data Solutions, Unidynamics, and Monsanto Research. She holds an MS in Global Technology and Development and a BS in Industrial Management from Arizona State University.